VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy

Documenti analoghi

• TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
  di: Papadopoulos Thomas, et al.
  Pubblicazione: (2007-08-01)
• Development and Validation of a Simplified Prognostic Score in SCLC
  di: Elodie Negre, MD, et al.
  Pubblicazione: (2020-03-01)
• Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
  di: Jin Yujuan, et al.
  Pubblicazione: (2023-05-01)
• Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
  di: Jiaping Liu, et al.
  Pubblicazione: (2024-06-01)
• Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
  di: Kana Hashimoto, MD, et al.
  Pubblicazione: (2024-11-01)